Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic osteomyelitis: a new therapeutical idea]

G. Carlino1, P. Trande, M. Muratore

  • 1A.U.S.L. LE/02, Maglie, Lecce; Italia. giorgiocarlino@medicitalia.it

Reumatismo
|June 29, 2002
PubMed
Summary

This study investigated iloprost and antibacterial therapy for chronic osteomyelitis. The treatment successfully prevented relapses and showed no side effects in a 43-year-old male patient over 15 months.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Delayed referral, socioeconomic status, and disease characteristics as factors associated with disabilities in rheumatoid arthritis patients: a multicenter observational study.

Reumatismo·2026
Same journal

Telerheumatology to improve first access outcomes in outpatients: a prospective monocentric pilot study.

Reumatismo·2026
Same journal

Hypocomplementemic urticarial vasculitis: a rare presentation revealing systemic lupus erythematosus and Sjögren's disease.

Reumatismo·2026
Same journal

Is there still someone laughing at Christopher Columbus?

Reumatismo·2026
Same journal

Concurrent herpetic hypertensive anterior uveitis and cytomegalovirus retinitis in a non-HIV patient with melanoma differentiation-associated gene-5 dermatomyositis: intravenous immunoglobulin comes to the rescue.

Reumatismo·2026
Same journal

Myasthenic syndrome in systemic lupus erythematosus successfully treated with plasma exchange: through one of the unexplored faces of neuropsychiatric involvement.

Reumatismo·2026

Area of Science:

  • Orthopedics
  • Vascular Medicine
  • Infectious Diseases

Background:

  • Chronic osteomyelitis is a persistent bone infection often characterized by frequent relapses.
  • Microcirculatory insufficiency in bone and soft tissue may contribute to treatment resistance and recurrence.
  • Post-traumatic osteomyelitis presents unique challenges due to associated tissue damage.

Purpose of the Study:

  • To evaluate the efficacy of iloprost combined with antibacterial drugs in managing chronic osteomyelitis.
  • To investigate the role of microcirculation improvement in treating refractory osteomyelitis.
  • To assess the safety and tolerability of this combined therapeutic approach.

Main Methods:

  • A case study of a 43-year-old male patient with recurrent post-traumatic chronic osteomyelitis.

Related Experiment Videos

  • Therapeutic intervention involving iloprost (a prostaglandin analog) and targeted antibacterial agents.
  • Monitoring for clinical relapse and adverse events over a 15-month follow-up period.

    • Main Results:

    • The patient experienced no clinically evident relapses of osteomyelitis during the 15-month treatment period.
    • No adverse side effects attributable to iloprost or antibacterial therapy were reported.
    • The treatment regimen appeared effective in managing the chronic infection.

    Conclusions:

    • Combined therapy with iloprost and antibacterial drugs shows promise for treating chronic osteomyelitis with microcirculatory compromise.
    • Iloprost may improve outcomes by enhancing vascularity in affected tissues.
    • This approach offers a potential strategy for preventing relapses in challenging osteomyelitis cases.